Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds
Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption activates the immune system and triggers an anti-tumor cell response that may be effectively used together with existing immunotherapy approaches in the treatment of solid tumors, with limited systemic toxicity.
David Tran Dongjiang Chen Emily Henderson Division Of Neuro Mcknight Brain Institute University Of Florida
Source: news-medical.net